Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2005
08/10/2005EP1560828A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands
08/10/2005EP1560827A1 Anti-infective agents
08/10/2005EP1560826A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
08/10/2005EP1560821A2 Antibacterial agents
08/10/2005EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
08/10/2005EP1560815A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
08/10/2005EP1560814A1 Process for making risperidone and intermediates therefor
08/10/2005EP1560584A2 Fab i inhibitors
08/10/2005EP1560582A2 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE
08/10/2005EP1560488A2 Antibacterial agents
08/10/2005EP1358187B1 Naphthyridine derivatives
08/10/2005EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors
08/10/2005EP1341788B1 Pyrazolopyridines
08/10/2005EP1244665B1 Triazatrinaphthyrins and the use thereof
08/10/2005EP1194425B1 Substituted benzimidazole
08/10/2005CN1653068A Novel diazabicyclic biaryl derivatives
08/10/2005CN1653067A Carbazole derivatives and their use as NPY5 receptor antagonists
08/10/2005CN1653066A Non-nucleoside reverse transcriptase inhibitors
08/10/2005CN1653065A Improved method for making nevirapine
08/10/2005CN1653050A Opioid and opioid-like compounds and uses thereof
08/10/2005CN1651444A Ruthenium (II) compounding material used for pH sensing and its preparation method
08/10/2005CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion
08/10/2005CN1650863A Antibiotic compositions for treatment of the eye, ear and nose
08/10/2005CN1214030C Prodrugs of imidazopyridine derivatives, medine containing same and use
08/10/2005CN1214009C antibacterial composition
08/09/2005US6927295 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators
08/09/2005US6927294 Nitrogen-containing heterocycles
08/09/2005US6927292 Pharmaceutical intermediates; nitrogen and oxygen fused heterocycles
08/09/2005US6927222 Compounds
08/09/2005US6927221 Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it
08/09/2005US6927220 Bicyclic-substituted 4-amino-pyridopyrimidine derivatives
08/09/2005US6927193 And aryl sulfide derivatives
08/09/2005US6926763 Gramnegative, grampositive bacteria infections
08/09/2005CA2188164C Benzamide compounds and pharmaceutical use thereof
08/09/2005CA2105518C Condensed heterocyclic compounds, their production and use
08/04/2005WO2005070932A2 Substituted heterocyclic compounds and methods of use
08/04/2005WO2005070930A2 Tetrahydrocarboline compounds as anticancer agents
08/04/2005WO2005070929A1 Vanilloid receptor ligands and their use in treatments
08/04/2005WO2005070928A1 2,4-dioxopyrimidine-based mesoionic pigments
08/04/2005WO2005070927A2 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
08/04/2005WO2005070920A1 Amino-benzazoles as p2y1 receptor inhibitors
08/04/2005WO2005070895A1 Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis
08/04/2005WO2005070894A1 Method for producing terrylen-3,4:11,12-tetracarbon acid di-imids
08/04/2005WO2005070891A2 Compounds and methods of use
08/04/2005WO2005070877A1 Diamino alcohols and their use as renin inhibitors
08/04/2005WO2005070871A2 Amino alcohol derivatives and their activity as renin inhibitors
08/04/2005WO2005070427A1 Compounds for the sustained reduction of body weight
08/04/2005WO2005069894A2 Conformationally constrained smac mimetics and the uses thereof
08/04/2005WO2005054244A3 Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain
08/04/2005WO2005049735A3 A process for aqueous milling of quinacridone pigments
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005WO2005011648A3 Use of cyclic bioisosteres of purine system derivatives for the treatment diseases caused by disorders of nitrergic and dopaminergic systems
08/04/2005WO2004092135A3 Substituted benzosulphonamide as potentiators of glutamate receptors
08/04/2005WO2004091485A3 Aminoquinoline compounds
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171181 Histamine-3 receptor modulators
08/04/2005US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171144 Imidazo[1,2-a] pyridine anxiolytics
08/04/2005US20050171143 selective Chemoattractant receptor-homologous molecule expressed on Th2 cells ( CRTH2 receptor) antagonist; activities for eosinphil and basophil infiltration; indol/carbazol-sulfonamide derivatives; antiallergenic agent; asthma, allergic rhinitis and dermatitis, polyarteritis, autoimmune disease
08/04/2005US20050171141 Modulators of muscarinic receptors
08/04/2005US20050171140 Prevent cholesterol biosynthesis; moderating blood serum lipid ; antidiabetic agents; obesity; hypotensive agents; osteoporosis; Alzheimer's disease; cardiovascular disorders; hormone replacement therapy
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171133 Therapeutic compounds
08/04/2005US20050171125 Novel alkoxypyridine-derivatives
08/04/2005US20050171123 Quinazoline derivatives as medicaments
08/04/2005US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders
08/04/2005US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors
08/04/2005US20050171108 Having 6-position substituent; sulfonylurea herbicides and intermediates; simple, low cost, high yield; transition metal catalytic reaction of leaving group with organometallic compound
08/04/2005US20050171101 Neurodegenerative diseases; diseases ascribed by NMDA- and NO-induced neurotoxicity ; ischemia; antiinflammatory; anticancer; antidiabetic; 2-{3-[4-Phenyl-3,6-dihydro-1(2H)-pyridyl]propyl}-6(5H)-phenanthridinone
08/04/2005US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050171087 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives
08/04/2005US20050171085 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
08/04/2005US20050171062 Administering to an animal having ocular hypertension or inflammatory bowel disease a piperidynly analog as for example 7-[2-oxo-6-((E)-3-oxo-oct-1-enyl)-piperidin-1-yl]-hept-5-ynoic acid methyl ester
08/04/2005US20050171049 Compounds for the treatment of ischemia
08/04/2005US20050169837 Coumarines useful as biomarkers
08/04/2005CA2554150A1 Tetrahydrocarboline compounds as anticancer agents
08/04/2005CA2553969A1 Vanilloid receptor ligands and their use in treatments
08/04/2005CA2553923A1 Substituted heterocyclic compounds and methods of use
08/04/2005CA2553874A1 Conformationally constrained smac mimetics and the uses thereof
08/04/2005CA2553840A1 Amino alcohol derivatives and their activity as renin inhibitors
08/04/2005CA2553831A1 Diamino alcohols and their use as renin inhibitors
08/04/2005CA2553649A1 Compounds for the sustained reduction of body weight
08/03/2005EP1559716A1 Pyrazolonaphthyridine derivative
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1559422A1 Receptor function controlling agent
08/03/2005EP1558614A1 Pyridopyrrolizine and pyridoindolizine derivatives
08/03/2005EP1558613A2 Pre-organized tricyclic integrase inhibitor compounds
08/03/2005EP1558612A1 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same
08/03/2005EP1558611A2 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
08/03/2005EP1558601A1 Selected cgrp antagonists, method for production and use thereof as medicament
08/03/2005EP1558600A1 Selected cgrp antagonists, method for production and use thereof as medicament
08/03/2005EP1558599A2 Heteroarylpiperidine modulators of chemokine receptor activity
08/03/2005EP1558585A1 Neurologically-active compounds
08/03/2005EP1558578A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
08/03/2005EP1558260A2 Quinazolinone compounds as calcilytics
08/03/2005EP1558256A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof
08/03/2005EP1558083A2 Compounds, compositions, and methods
08/03/2005EP1357124B1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
1 ... 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 ... 646